Zentalis Pharmaceuticals Inc reports results for the quarter - Earnings Summary

Zentalis Pharmaceuticals

13/11/2024 20:23

* Zentalis Pharmaceuticals Inc  ZNTL.OQ  reported a
quarterly
adjusted loss of 56 cents​​ per share for the quarter , higher
than the same quarter last year, when the company reported EPS
of -79 cents.  The mean expectation of eleven analysts for the
quarter was for a loss of 91 cents per share. Wall Street
expected results to range from -99 cents to -81 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Zentalis Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 56 cents​.
    * The company reported a quarterly loss of $40.16 million.
    * Zentalis Pharmaceuticals Inc shares had risen by 0.8% this
quarter and lost 75.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Zentalis
Pharmaceuticals Inc is 8.00 
This summary was machine generated from LSEG data November 13 at
08:23 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.91          -0.56          Beat
 Jun. 30 2024      -0.84          -1.24          Missed
 Mar. 31 2024      -0.77          0.14           Beat
 Dec. 31 2023      -0.92          -0.93          Missed